A nurse is reinforcing teaching with a client who is dependent on nicotine and wishes to discontinue smoking. The nurse should inform the client that which of the following is a manifestation of nicotine withdrawal?

A.While it's important to document visitors and support persons, this information may not be considered crucial for the change-of-shift report unless it directly impacts the client's care or well-being.

B. The client received the prescribed antibiotic every 8 hours: This is important information, but it is typically documented in the medication administration record (MAR) and does not need to be included in the verbal report unless there were issues or changes related to the medication.

C. The client reports pain is reduced when positioned on his side: This is significant information as it informs the incoming nurse about the client's preferred position for pain management. It helps guide the nurse in providing comfort measures and appropriate positioning for the client. The client's mother died 4 years ago from breast cancer: This information may not be considered vital for the change-of-shift report unless it directly impacts the client's current condition or ongoing care.

D. The client's mother died 4 years ago from breast cancer: This information may not be considered vital for the change-of-shift report unless it directly impacts the client's current condition or ongoing care.

Explanation B.Triiodothyronine

Levothyroxine is a synthetic form of the thyroid hormone thyroxine (T4). It is converted to triiodothyronine (T3), the active form of the thyroid hormone, in the body. Monitoring the levels of triiodothyronine (T3) can help assess the effectiveness of levothyroxine therapy and ensure that the client's thyroid hormone levels are within the desired therapeutic range.

Serum potassium levels in (option A) should not be monitored because they are not directly affected by levothyroxine. However, imbalances in electrolytes can occur in some individuals with thyroid disorders. Electrolyte levels may be monitored, but it is not the primary focus of monitoring for levothyroxine therapy.

Blood urea nitrogen (BUN) in (option C) should not be monitored because it is a test used to assess kidney function and is not directly related to monitoring levothyroxine therapy.

Prothrombin time (PT) in (option D) should not be monitored because it is a test used to evaluate the clotting function of the blood and is not specifically related to monitoring levothyroxine therapy.